{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:13:14Z","timestamp":1790986394831,"version":"4.1.0"},"reference-count":40,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,1,15]],"date-time":"2008-01-15T00:00:00Z","timestamp":1200355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:p>TrkB is a neurotrophic tyrosine kinase receptor (Trk). To investigate its role in anoikis suppression in human ovarian cancer, we used reverse transcription\u2013polymerase chain reaction and real\u2010time polymerase chain reaction, immunohistochemistry, and western blotting to compare the expression levels of TrkB and its ligand brain\u2010derived neurotrophic factor between (i) 20 epithelial ovarian cancers, their multicellular spheroids in ascites or great omentum metastatic lesions, and eight borderline or benign ovarian tumors, as well as four normal ovarian tissues; and (ii) three ovarian cancer cell lines cultured under different conditions: monolayer adhesive culture (adhesive cells), anchorage\u2010independent culture (cell spheroids), and trypsinized cell spheroids placed in monolayer adhesive dishes (cell spheroids replaced). TrkB and brain\u2010derived neurotrophic factor were overexpressed in epithelial ovarian cancers, and full\u2010length TrkB was more often overexpressed in high\u2010grade carcinomas and multicellular spheroids in ascites. Expression of TrkB mRNA was higher in OVCAR\u20103 cell spheroids than in adhesive cells. The expression of full\u2010length TrkB protein was highest in OVCAR\u20103 cell spheroids, but its precursor was expressed highly in OVCAR\u20103 cells under all three culture conditions. The relationship between TrkB overexpression and phosphatidylinositol 3\u2032\u2010kinase (PI3K)\u2013AKT pathway activation in OVCAR\u20103 cells was studied by western blotting and RNA interference. The PI3K\u2013AKT pathway was highly activated in anoikis\u2010survived cells and was inhibited when TrkB was silenced by small interfering RNA. Finally, the chemosensitivity and invasiveness of OVCAR\u20103 cells were examined by 3\u2010(4,5\u2010dimethylthiazol\u20102\u2010yl)\u20102,5\u2010diphenyltetrazolium, fluorescence\u2010activated cell sorting, Matrigel invasion assay, and <jats:italic>in\u00a0vivo <\/jats:italic>studies. Adhesive cells showed higher chemosensitivity and lower invasion ability than anoikis\u2010survived cells. Our study suggests that TrkB might mediate anoikis suppression by activating the PI3K\u2013AKT pathway in ovarian cancer cells. (<jats:italic>Cancer Sci<\/jats:italic> 2008; 99: 543\u2013552)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2007.00722.x","type":"journal-article","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T09:35:07Z","timestamp":1202290507000},"page":"543-552","source":"Crossref","is-referenced-by-count":105,"title":["Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer"],"prefix":"10.1111","volume":"99","author":[{"given":"Xiaohui","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,1,15]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1173"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-05-0192"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1886"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.08.028"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M508664200"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature02765"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M205202200"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2005.02.051"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2042.2001.00331.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.440.11.2"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.219.65.1"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/08977190500233813"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1082596"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-005-5490-8"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-3606"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1819"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600566"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.11.051"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10399"},{"key":"e_1_2_7_21_2","first-page":"1087","article-title":"Inhibition of phosphatidylinositol3\u2032\u2010kinase increases the efficacy of paclitaxel in in\u00a0vitro and in\u00a0vivo ovarian cancer models","volume":"15","author":"Hu L","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0958"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-05-0445"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.12.019"},{"key":"e_1_2_7_25_2","first-page":"4837","article-title":"Induction of anoikis and suppression of human ovarian tumor growth in\u00a0vivo by down\u2010regulation of Bcl\u2010XL","volume":"61","author":"Frankel A","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1125"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2007.00565.x"},{"key":"e_1_2_7_28_2","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1073\/pnas.082117599","article-title":"DNA vector\u2010based RNAi technology to suppress gene expression in mammalian cells","volume":"99","author":"Sui G","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_2_7_29_2","first-page":"3457","article-title":"Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients","volume":"7","author":"Davidson B","year":"2001","journal-title":"Clin Cancer Res"},{"key":"e_1_2_7_30_2","first-page":"2248","article-title":"Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma","volume":"9","author":"Davidson B","year":"2003","journal-title":"Clin Cancer Res"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1242\/dev.00707"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2003.12.001"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M211522200"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203805"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208000"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/376599a0"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21766"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.151.3.483"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M108975200"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00422.2003"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.12.033"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2007.00722.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2007.00722.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T23:49:32Z","timestamp":1697240972000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2007.00722.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,15]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["10.1111\/j.1349-7006.2007.00722.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2007.00722.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,15]]}}}